Venus Remedies Limited (VENUSREM) Share Price & AI Investment Analysis

Venus Remedies Limited engages in the pharmaceutical business in India, Latin America, Europe, the Middle East, Africa, Asia, and internationally. The company is involved in the research and development of solutions focusing on antimicrobial resistance, oncology, skin and wound care, and pain management. It also provides analgesic, analgesic and antipyretic, antibiotic, antidiabetic anticoagulant, antiemetic, antiviral, cardiac, cardiovascular, CNS, disinfectant and antiseptic, gastro therapy, gastro therapy, hepatoprotective, hormones (steroid), immunostimulating agent, iron supplements, muco. Track Venus Remedies Limited's live NSE:VENUSREM share price ₹1,582.20 (+2.09%), market cap ₹₹21B, P/E 18.2. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for VENUSREM — real-time NSE India stock intelligence.